Effects of Inspiratory Muscle Training After Covid-19 (ReCOV)
IMT-ReCov
1 other identifier
interventional
44
1 country
1
Brief Summary
Initially, it was suspected that Covid-19 would primarily affect the airways, but several studies have now shown that it is a disease with multisystem manifestations. Covid-19 has the potential to affect physical, cognitive, and psychological functions in multiple ways. It has been clear that a significant proportion of patients with Covid-19 develop long-term symptoms. The term post-acute Covid-19 syndrome (PACS) is now used to describe the wide range of prolonged symptoms following the infection. Patients who have been in hospital for Covid-19 for a long time may need specialized rehabilitation, however, also non-hospitalized patients with mild symptoms may need specific rehabilitation to be able to meet the complex symptoms and problems that may arise. Previous studies on the recovery and rehabilitation after other coronavirus shows the importance to develop tailored interventions so that these patients receive appropriate rehabilitation The aim of this study is to evaluate the effects of inspiratory muscle training on adult patients with PACS and decreased respiratory muscle strength. A randomized controlled trial will be used. A total of 90 adult patients with PACS and 80 % or less of predicted value in inspiratory muscle strength (maximal inspiratory pressure) will be eligible for enrollment. Patients will be randomized either to an intervention group or a control group. The intervention will consist of inspiratory muscle training performed twice daily for 8 weeks. This will be combined with an 8-week physical exercise training program. The control group will perform the same physical exercise training according to standard care. All measurements will be performed at baseline and after 8 weeks. Primary outcome is maximal inspiratory pressure. Secondary outcomes are: Maximal expiratory pressure, pulmonary function, physical capacity, physical activity, respiratory status and symptoms, health-related quality of life, work ability, fatigue, self-reported outcome measure of physical function and voice function. Covid-19 has the potential to affect physical, cognitive, and psychological functions in multiple ways and lead to a negative impact on quality of life in the long-term perspective. Therefore, development of a rehabilitation program with specific tailored interventions will be necessary to improve physical and psychological function, as well as health-related quality of life and work ability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable covid19
Started Aug 2021
Longer than P75 for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2021
CompletedStudy Start
First participant enrolled
August 24, 2021
CompletedFirst Posted
Study publicly available on registry
August 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedSeptember 10, 2025
September 1, 2025
3.4 years
August 24, 2021
September 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Maximal Inspiratory Pressure (MIP)
Change in MIP measured in cmH20, expressed as percentage of predictive value, with a Respiratory Pressure Meter (Micro RPM)
Measured before and after the intervention period of 8 weeks to detect a change
Secondary Outcomes (26)
Change in Maximal Expiratory Pressure (MEP)
Measured before and after the intervention period of 8 weeks to detect a change
Change in Lung function
Measured before and after the intervention period of 8 weeks to detect a change
Change in walking distance during 6 minute walk test, expressed as percentage of predictive value,
Measured before and after the intervention period of 8 weeks to detect a change
Change in oxygen saturation during 6 minute walk test
Measured before and after the intervention period of 8 weeks to detect a change
Change in oxygen desaturation during 6 minute walk test
Measured before and after the intervention period of 8 weeks to detect a change
- +21 more secondary outcomes
Study Arms (2)
Intervention: inspiratory muscle training + physical exercise
EXPERIMENTALInspiratory muscle training (IMT) twice a day for 8 weeks combined with a physical exercise program at least two times a week for 8 weeks.
Active control: physical exercise
ACTIVE COMPARATORA physical exercise program at least two times a week for 8 weeks.
Interventions
Inspiratory muscle training (IMT) at 20-50 % of maximal inspiratory pressure (MIP), 2 x 30 repetitions, twice a day for 8 weeks.
A physical exercise program at least two times a week for 8 weeks. Including strength, aerobic and mobility exercises.
Eligibility Criteria
You may qualify if:
- Adult patients (≥18 years) who have undergone Covid-19 and have 80% or less of the lower limit of predicted value in maximal inspiratory pressure (MIP).
You may not qualify if:
- Physical och cognitive dysfunction which makes it impossible to carry out measurements and interventions. Already on-going intervention with inspiratory muscle training.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Karolinska University Hospitalcollaborator
Study Sites (1)
Karolinska University Hospital
Stockholm, 17176, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Malin Nygren Bonnier, PhD
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The interventions were not possible to mask for participants or health care professionals (physiotherapist leading interventions). The physiotherapists who performed the tests after interventions were blinded to the group allocation. All data were coded and group assignment was blinded for the outcome analyses.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physiotherapist, Senior lecturer and Associate Professor
Study Record Dates
First Submitted
August 24, 2021
First Posted
August 27, 2021
Study Start
August 24, 2021
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
September 10, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share